nash semaglutide Current and future pharmacological therapies for NAFLD/NASH | Journal of Gastroenterology Phase 3 Trial of Semaglutide

If your liver is overwhelmed, your skin often shows it through dullness or spots

Blood cell problems: Patients taking spironolactone have been reported to have low white blood cell and platelet levels, which can raise the risk of infections or bleeding episodes

Temporary nausea, semaglutide fatigue , or headache can occur as your body adjusts to a higher dose

J Endocrinol (2009) 200(1):5361

Over time, these cumulative effectsappetite suppression, extended satiety, improved glucose patterns, and modest increases in digestive energy expenditurecombine to create a substantial calorie deficit without the metabolic slowdown that typically accompanies restrictive dieting

Special considerations in people who are immunocompromised